FDA Inspection 1268483 — Penn State Health Holy Spirit Medical Center
The FDA completed an inspection of Penn State Health Holy Spirit Medical Center on April 24, 2025 in Camp Hill, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 24, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Camp Hill, PA (United States)